United States · Venture startup
2 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$21Mraised across 2 rounds since 2004, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
From historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Enanta Pharmaceuticals's investors include Oxford Bioscience Partners, Advent International, Bioventures Investors, Techno Venture Management and Yasuda Enterprise Development, and 3 more on record.
Enanta Pharmaceuticals has raised $21M across 2 rounds since 2004.
Enanta Pharmaceuticals's most recent round was a Venture of $9.2M in Sept 2013.
Enanta Pharmaceuticals's largest round on record is $12M (Venture), in Jan 2004.
Enanta Pharmaceuticals's first round on record, in Jan 2004, was backed by Oxford Bioscience Partners, Advent International and Bioventures Investors and 5 others.
Enanta Pharmaceuticals's latest named round is a Venture, in Sept 2013.
Enanta Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
